Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-042207
Filing Date
2022-02-14
Accepted
2022-02-14 17:15:17
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2017 GP, L.L.C.GV 2017 GP, L.P.GV 2019 GP, L.L.C.GV 2019 GP, L.P.GV 2019, L.P.VERILY LIFE SCIENCES LLCXXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d489212dsc13g.htm SC 13G 204012
2 EX-99.A d489212dex99a.htm EX-99.A 13912
  Complete submission text file 0001193125-22-042207.txt   219675
Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2017, L.P. (Filed by) CIK: 0001733340 (see all company filings)

EIN.: 352587854 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Subject) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92605 | Film No.: 22634763
SIC: 2834 Pharmaceutical Preparations